Jul 19, 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Jul 10, 2019
Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections
Jun 27, 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
Jun 18, 2019
Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York
Jun 13, 2019
Qpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
Jun 10, 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Jun 03, 2019
"Superbugs" Are No Match for the Advanced Penetration Technology(TM) Topical Platform
Jun 03, 2019
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada
May 30, 2019
Nalco Water Launches LegionGuard™ LG25 to Help Reduce Legionella Risk
May 28, 2019
Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient
May 07, 2019
Landsec and Spartan Bioscience Trial the World's First On-Site Legionella DNA Test in the UK
May 01, 2019
Legionella Interactive Workshop for Healthcare Promotes Collaboration
Apr 01, 2019
Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ECCMID
Mar 18, 2019
Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients
Feb 19, 2019
Clear Labs Announces Salmonella Serotyping Capabilities Powered by Next-Generation Sequencing (NGS)
Feb 13, 2019
Public Health Notice - Information for Canadians who have received or are considering medical procedures in Mexico
Jan 30, 2019
Phigenics Will Host Water and Legionella Risk Management Summit
Jan 03, 2019
VenatoRx Pharmaceuticals Joins Antimicrobials Working Group
Dec 10, 2018
Allosource Scientists Contribute To NASA's Jet Propulsion Laboratory Study On Antimicrobial Survivability On The International Space Station
Nov 20, 2018
Allergan Announces FDA Acceptance of Supplemental New Drug Application for AVYCAZ® (ceftazidime and avibactam)